Clinical trial

A Study to Evaluate the Effects of Azithromycin on MAC Disease Prevention in…

NCT00000947 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed

Key facts

NCT number NCT00000947
Title A Study to Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients
Official title A Randomized, Double-Blind, Placebo-Controlled Trial of Prophylaxis for Disseminated Mycobacterium Avium Complex Disease and Bacterial Pneumonia Versus Deferred Prophylaxis in HIV-Infected Patients Who Experience Rebound in CD4+ Cell Count Due to Active Antiretroviral Therapy
Lead sponsor National Institute of Allergy and Infectious Diseases (NIAID), NIH
Status Completed
Study type Interventional
Conditions Mycobacterium Avium-intracellulare Infection, HIV Infections
Intervention type Drug
Interventions Azithromycin
Enrollment 850
Completion Jul 1, 2000
First posted Aug 31, 2001
Last update posted Nov 3, 2021
Countries United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies